SELECTIVE DELETION OF TUMOR-ASSOCIATED MARCHPHAGE AND NORMALIZATION OF MEYLOID SUPPRESSOR CELLS AS NOVEL OVARIAN CANCER THERAPY

Scripps Research Institute, La Jolla CA

Investigators